Vivo Bio Tech executes lease deed with Andhra Pradesh Med Tech Zone

31 Jan 2022 Evaluate

Vivo Bio Tech has executed a lease deed with Andhra Pradesh Med Tech Zone for setting up a new facility at Andhra Pradesh Med Tech Zone (AMTZ) Campus, Pragati Maidan, Visakhapatnam, Andhra Pradesh. The new facility adds Pigs and Canines to Vivo’s small animal portfolio. The new facility, when fully functional can hold upto 178 large animals. The complete facility has been taken over by Vivo. By end of March, vivo is looking at operationalizing 25% of the capacity by end of FY 22-23, complete facility will be operational.

This new acquisition will complete Biology portfolio of Vivo. Currently Vivo is offering services related to In-vitro studies, In-vivo studies, Physico- chemical studies, Regulatory and non-regulatory toxicology, Pharmacology, ADME, DMPK studies and sale of SPF rats and mice, Guinea Pigs and Rabbits and diagnostic services. The new addition will add medical device testing, DMPK, regulatory and no regulatory toxicology testing services on large animals.

Vivo Bio Tech was incorporated on February 12, 1987 as Golden Growth Fund, Hyderabad-based Vivo Bio Tech (VBTL) is a contract research company engaged in biotechnology and pharma drug discovery activities.

Vivo Bio Tech Share Price

41.60 -2.05 (-4.70%)
09-May-2024 16:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1493.35
Dr. Reddys Lab 5879.05
Cipla 1358.80
Zydus Lifesciences 967.80
Lupin 1585.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.